AMANDA WRIGHT: Open Payments
NPI 1922244086 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 35 payments from 14 companies in 2025. Trend: 2023 $880 · 2024 $985 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $132 |
| Janssen Biotech, Inc. | 4 | $76 |
| Incyte Corporation | 3 | $71 |
| UCB, Inc. | 2 | $47 |
| PFIZER INC. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| ABBVIE INC. | 1 | $29 |
| GENZYME CORPORATION | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
Products named: ILUMYA, TREMFYA, COSENTYX, OPZELURA, Bimzelx, CIBINQO, Sotyktu, Rhapsido.
Industry payments across SC — which companies pay providers there.
